Melatonin: New applications in clinical and veterinary medicine, plant physiology and industry

Neuroendocrinology Letters

Volumn 32, Issue 5, 2011, Pages 575-587

  Reiter, Russel J ^a   Coto Montes, Ana ^a   Boga, Jose Antonio ^a   Fuentes Broto, Lorena ^a   Rosales Corral, Sergio ^a   Tan, Dun Xian ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

Author keywords

Auxin like actions; Bio compatible reductant; Fetus; In vitro fertilization; Industrial use; Melatonin; Placenta; Plants

Indexed keywords

CELECOXIB; GRAPHENE; HYDRAZINE; MELATONIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BREAST CANCER; CIRCADIAN RHYTHM; CLINICAL MEDICINE; EMBRYO TRANSFER; ENDOMETRIOSIS; FERTILIZATION IN VITRO; FETUS DEVELOPMENT; GERMINATION; HUMAN; INDUSTRY; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; OOCYTE MATURATION; OVARY CYCLE; OVARY FUNCTION; OVULATION; OXIDATIVE STRESS; PANCREAS CANCER; PLANT GROWTH; PLANT PHYSIOLOGY; PREECLAMPSIA; PROSTATE CANCER; REVIEW; SURVIVAL RATE; VETERINARY MEDICINE;

EID: 84857394757     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (205)

1. Acuna-Castroviejo D, Reiter RJ, Menendez-Pelaez A, Pablos MI, Burgos A (1994). Characterization of high affinity melatonin binding sites in purified cell nuclei of rat liver. J Pineal Res. 16: 100-112.
2. Acuna-Castroviejo D, Martin M, Macias M, Escames G, Leon J, Khaldy H, et al. (2001). Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res. 30: 65-74. (Pubitemid 32176208)
3. Acuna-Castroviejo D, Lopez LC, Escames G, Lopez A, Garcia JA, Reiter RJ (2011). Melatonin - mitochondria interplay in health and disease. Curr Top Med Chem. 11: 211-240.
4. Afreen F, Zobayed SMA, Kozai T (2006). Melatonin in Glycyrrhiza uralensis: response of plant roots to spectral quality of light and UV-B radiation. J Pineal Res. 4: 108-115. (Pubitemid 44141744)
5. Akhaven O, Ghaderi E (2010). Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano. 4: 5731-5736.
6. Arnao MB, Hernandez-Ruiz J (2007). Melatonin promotes adventitious and lateral root growth in etiolated hypocotyls of Lupinus albus L. J Pineal Res. 42: 147-152. (Pubitemid 46233060)
7. Axelrod J (1970). The pineal gland. Endeavor. 29: 144-148.
8. Axelrod J, Wurtman RJ (1968). Photic and neural control of indoleamine metabolism in the rat pineal gland. Adv Pharmacol. 6 (Part A): 157-166.
9. Blask DE, Lemus-Wilson AM, Wilson ST (1992). Breast cancer: a model system for studying the neuroendocrine role of pineal melatonin in oncology. Biochem Soc Trans. 20: 309-311.
10. Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, Sauer LA, et al. (2005). Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude mice. Cancer Res. 65: 11174-11184. (Pubitemid 41713389)
11. Benedetto C, Marozio L, Tancredi A, Picardo E, Nardolillo P, Tanella AM, et al. (2011). Biochemistry of HELLP syndrome. Adv Clin Med. 53: 85-104.
12. Benot S, Goberna R, Reiter RJ, Garcia-Maurino S, Osuna C, Guerrero JM (1999). Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J Pineal Res. 27: 59-64. (Pubitemid 29359459)
13. Benson B (1980). Continued chemical and physiological studies with antigonadotropic fractions from extracts of bovine pineal glands. J Neural Transm. 48: 261-269.
14. Bonnefont-Rousselot D, Collin F, Jore D, Gardes-Albert M (2011). Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. J Pineal Res. 50: 328-335.
15. Burkhardt S, Tan DX, Manchester LC, Hardeland R, Reiter RJ (2001). Detection and quantification of the antioxidant melatonin in Montmorency and Balaton tart cherries. J Agri Food Chem. 49: 4898-4902. (Pubitemid 32988737)
16. Brzezinski A, Seibel MM, Lynch HJ, Deng MH, Wurtman RJ (1987). Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab. 64: 865-867. (Pubitemid 17044561)
17. Calvo-Guirado JL, Gomez-Moreno G, Lopez-Mari L, Guardia J, Marinez-Gonzalez JM, Barone A, et al. (2010). Actions of melatonin mixed with collagenized porcine bone versus porcine bone only on osteointegration of dental implants. J Pineal Res. 48: 194-203.
18. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ (2005). A review of the multiple actions of melatonin on the immune system. Endocrine. 27: 189-200. (Pubitemid 41558451)
19. Carter DS, Goldman BD (1983). Antigonadal effects of timed melatonin infusion in pinealectomized Djungarian hamsters (Phodopus sungorus sungorus): duration is the critical parameter. Endocrinology. 113: 1261-1267. (Pubitemid 13009132)
20. Casao A, Mendoza N, Perez-Pe R, Grasa P, Abecia JA, Forcada F, et al. (2010). Melatonin prevents capacitation and apoptotic-like changes of ram spermatozoa and increases fertility rate. J Pineal Res. 48: 39-46.
21. Chen G, Huo Y, Tan DX, Liang Z, Zhang W, Zhang Y (2003). Melatonin in Chinese medicinal herbs. Life Sci. 73: 19-26. (Pubitemid 36515132)
22. Clarke IJ, Smith JT, Caraty A, Goodman RL, Lehman MN (2009). Kisspeptin and seasonality in sheep. Peptides. 30: 154-163.
23. Claustrat B, Brun J, Borson-Chazot F, Cohen-Tannoudje D, Claustrat F, Julien J, etal. (2010). Suppression of melatonin secretion in healthy subjects with eyeglass LED delivery system. Neuroendocrinol Lett. 31: 330-335.
24. Coleman MP, Reiter RJ (1992). Breast cancer, blindness and melatonin. Eur J Cancer. 28: 501-503.
25. Cos S, Sanchez-Barcelo EJ (1994). Differences between pulsatile or continuous exposure to melatonin on MCF-7 human breast cancer cell proliferation. Cancer Lett. 85: 105-109. (Pubitemid 24280169)
26. Das A, McDowell M, Pava MJ, Smith JA, Reiter RJ, Woodward JJ, et al. (2010). The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-α toxicity involves membrane melatonin receptors. J Pineal Res. 48: 157-169.
27. Das Gupta TK, Terez J (1967). Influence of the pineal gland on the growth and spread of melanoma in the hamster. Cancer Res. 27: 1306-1311.
28. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, Kaski JC, Reiter RJ (2010). Melatonin and circadian biology in human cardiovascular disease. J Pineal Res. 49: 14-22.
29. Dubbels R, Reiter RJ, Klenke E, Goebel A, Schnakenberg E, Ehlers C, et al. (1995). Melatonin in edible plants identified by radioimmunoassay and high performance liquid chromatography-mass spectroscopy. J Pineal Res. 18: 28-31.
30. Dubocovich ML, Markowska M (2005). Functional MT1 and MT2 melatonin receptors in mammals. Endocrine. 27: 101-111.
31. Erren TC, Reiter RJ (2008). A generalized theory of carcinogenesis due to chronodisruption. Neuroendocrinol Lett. 29: 815-821.
32. Erren TC, Falaturi P, Reiter RJ (2010). Research into chronodisruption cancer theory: the imperative for causal clarification and the danger of causal reductionism. Neuroendocrinol Lett. 31: 1-3.
33. Esfandiar A, Akhavan O, Irajizad A (in press). Melatonin as a powerful bio-antioxidant for reduction of graphene oxide. J Nat Chem. DOI: 10.139/c1jm10151j.
34. Espey LL, Ujioka T, Okamura H, Richards JS (2003). Metallothionein-1 messenger RNA transcription in steroid-secreting cells of the rat ovary during the periovulatory period. Biol Reprod. 68: 1895-1902. (Pubitemid 36519800)
35. Figueiro MG, Rea MS (2010). Lack of short-wavelength light during the school day delays dim light melatonin onset (DLMO) in middle school students. Neuroendocrinol Lett. 31: 92-96.
36. Finocchiaro L, Callebert J, Launay JM, Jallon JM (1988). Melatonin biosynthesis in Drosophila: its nature and its effects. J Neurochem. 50: 382-387.
37. Focada F, Abecia JA, Cebrian-Perez JA, Muino-Blanco T, Valares JA, Palacin I, et al. (2006). The effect of melatonin implants during the seasonal anestrus on embryo production and superovulation in aged high prolificacy Rasa aragonesa ewes. Theriogenology. 65: 356-365. (Pubitemid 41820374)
38. Fowden AL, Giussani DA, Forhead AJ (2006). Intrauterine programming of physiological systems: causes and consequences. Physiology. 21: 29-37. (Pubitemid 43752515)
39. Franco MC, Akamine EH, Reboucas N, Carvalho MH, Tostes RC, Nigro D, et al. (2007). Long-term effects of intrauterine malnutrition on vascular function in female offspring: implications of oxidative stress. Life Sci. 80: 709-715. (Pubitemid 46127564)
40. Galano A, Tan DX, Reiter RJ (2011). Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res. 51: 1-16.
41. Garai J, Molnar V, Varga T, Koppan M, Torok A, Bodis J (2006). Endometriosis: harmful survival of an ectopic tissue. Front Biosci. 11: 595-619. (Pubitemid 43258166)
42. Garcia-Macia M, Vega-Naredo I, De Gonzalo-Calvo D, Rodriguez-Gonzalez SM, Camello PJ, Camello-Almaraz C, etal. (2011). Melatonin induces neural SOD2 expression independent of the NF-kappaB pathway and improves the mitochondrial population and function in old mice. J Pineal Res. 50: 54-63.
43. Gonzalez A, Castillo-Vaquero AD, Miro-Moran A, Tapia JA, Salido GM (2011). Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology. J Pineal Res. 50: 250-260.
44. Gitto E, Tan DX, Reiter RJ, Karbownik M, Manchester LC, Cuzzoerea S, et al. (2001). Individual and synergistic actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in rat liver homogenates. J Pharm Pharmacol. 53: 1393-1401. (Pubitemid 32982257)
45. Güney M, Oral B, Karakan N, Mungan T (2008). Regression of endometrial expiants in a rat model of endometriosis treated with melatonin. Fertil Steril. 89: 934-942. (Pubitemid 351491219)
46. Hamm HE, Menaker M (1980). Retinal rhythms in chicks: circadian variation in melatonin and serotonin N-acetyltransferase activity. Proc Natl Acad Sci USA. 77: 4998-5002.
47. Han SS, Jang JY, Kim SW, Kim WH, Lee KU, Park YH (2006). Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas. 32: 271-275.
48. Hardeland R (2009). Melatonin: signaling mechanisms of a pleiotropic agent. Biofactors. 35: 183-192.
49. Hardeland R, Poeggeler B (2003). Non-vertebrate melatonin. J Pineal Res. 34: 233-241. (Pubitemid 36469768)
50. Hardeland R, Tan DX, Reiter RJ (2009). Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res. 47: 109-126.
51. Hardeland R, Cardinali DP, Srinivasan V, Spence DW, Brown GM, Pandi-Perumal SR (2011). Melatonin - a pleiotropic orchestrating regulator molecule. Prog Neurobiol. 93: 350-384.
52. Hattori A, Migitaka H, Iigo M, Itoh M, Yamamato K, OhtaniKandro R. et al. (1995). Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptor in vertebrates. Biochem Mol Biol Int. 35: 627-634. (Pubitemid 26177836)
53. Hernandez J, Cano A, Arnao MB (2005). Melatonin acts as a growth-stimulating compound in some monocot species. J Pineal Res. 39: 137-142. (Pubitemid 41140751)
54. Hoffman RA, Reiter RJ (1965). Pineal gland: influence on gonads of male hamsters. Science. 148: 1609-1611.
55. Hoffman RA, Reiter RJ (1966). Responses of some endocrine organs of female hamsters to pinealectomy and light. Life Sci. 5: 1147-1151.
56. Hong Y, Palakska KJ, Park K, Park S, Kim HD, Reiter RJ, et al. (2010). Melatonin plus exercise-based neurorehabilitative therapy for spinal cord injury. J Pineal Res. 49: 201-209.
57. Huang SH, Cao XJ, Lui W, Shi XY, Wei W (2010). Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice. J Pineal Res. 48: 109-116.
58. Huang X, Mazza G (2011). Application of LC and LC-MS to the analysis of melatonin and serotonin in edible plants. Crit Rev Food Sci Nutr. 51: 269-284.
59. Huether G (1994). Melatonin synthesis in the gastrointestinal tract and the impact of nutritional factors on circulating melatonin. Ann NY Acad Sci. 719: 146-158.
60. Iriti M (2009). Melatonin in grape, not just a myth, maybe a panacea. J Pineal Res. 46: 353.
61. Iriti M, Vorani EM, Vitalini S (2010). Melatonin in traditional Mediterranean diets. J Pineal Res. 49: 101-105.
62. Itoh MT, Ishizuka B, Kuribayashi Y, Amemiya A, Sumi Y (1999). Melatonin, its precursors, and synthesizing enzyme activities in the human ovary. Mol Human Reprod. 5: 402-408. (Pubitemid 29202195)
63. Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C (1999). Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci. 50: 271-279. (Pubitemid 29407090)
64. Janas KM, Ciupinska E, Posmyk MM (2009). Melatonin applied by hydropriming as a biostimulator improving sweet corn (lea mays L.) seedling growth in abiotic stress conditions. In: Progress in Environmental Science and Technology, Vol II, Part A, Editors: Li SC, Wang YJ, Cao FX, Huang P, Zhang Y, Science Press, Beijing 383-388.
65. 2+-mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res. 48: 20-38.
66. Jung-Hynes B, Reiter RJ, Ahmad N (2010a). Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res. 48: 9-19.
67. Jung-Hynes B, Huang W, Reiter RJ, Ahmad N (2010b). Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells. J Pineal Res. 49: 60-68.
68. Kang K, Kong K, Park S, Natsagdorj V, Kim YS, Bask K (2011). Molecular cloning of a plant N-acetylserotonin methyltransferase and its expression characteristics in rice. J Pineal Res. 50: 304-309.
69. Kang K, Lee K, Park S, Kim YS, Bask K (2010). Enhanced production of melatonin by extopic overexpression of human serotonin N-acetyltransferase plays a role in cold resistance in transgenic rice seedlings. J Pineal Res. 49: 176-182.
70. Kennaway DJ (2002). Programming the fetal suprachiasmatic nucleus and subsequent adult rhythmicity. Trends Endocrinol Metab. 13: 398-402.
71. Kim MC, Hwang GS, Ruoff RS (2009). Epoxide reduction with hydrazine on graphene: a first principles of study. J Chem Phys. 131: 064704-064705.
72. Kitay JI, Altschule MD (1954). The Pineal Gland: A Review of Physiological Literature. Harvard University Press, Cambridge, MA.
73. Klein DC, Weller JL (1970). Indole metabolism in the pineal gland: a circadian rhythm in N-acetyltransferase. Science. 169: 1093-1095.
74. Kloog I, Stevens RG, Haim A, Portnov RA (2010). Nighttime light level co-distributes with breast cancer incidence worldwide. Cancer Causes Control 20: 2059-2068.
75. Koppisetti S, Jenigiri B, Terron MP, Tengattini S, Tamura H, Flores LJ, et al. (2008). Reactive oxygen species and the hypomobility of the gall bladder as targets for the treatment of gallstones with melatonin: a review. Dig Dis Sci. 53: 2592-2603.
76. Korkmaz A, Kunak ZI, Paredes SD, Yaren H, Tan DX, Reiter RJ (2008). The use of melatonin to combat mustard toxicity: review. Neuroendocrinol Lett. 29: 614-619.
77. Korkmaz A, Sanchez-Barcelo EJ, Tan DX, Reiter RJ (2009). Role of melatonin in the epigenetic regulation of breast cancer. Breast Cancer Res. Treat. 115: 13-27.
78. Kudin KN, Ozbas B, Schniepp HC, Prudhommne RK, Aksay IA, Car R (2008). Raman spectra of graphite oxide and functionalized graphene sheets. Nano Lett. 8: 36-41. (Pubitemid 351177772)
79. Lanoix D, Beghdadi H, Lafond J, Vaillancourt C (2008). Human placental trophoblasts synthesize melatonin and express its receptors. J Pineal Res. 45: 50-60. (Pubitemid 351986262)
80. Lapin V, Ebels I (1976). Effects of some low molecular weight sheep pineal fractions and melatonin on different tumors in rats and mice. Oncology. 33: 110-113. (Pubitemid 8012205)
81. Lee JW, Davis JM (2011). Future applications of antioxidants in premature infants. Curr Opin Pediatr. 23: 161-166.
82. Leja-Szpak A, Jaworek J, Pierzchalski P, Reiter RJ (2010). Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res. 49: 248-255.
83. Leon-Blanco MM, Guerrero JM, Reiter RJ, Calvo JR, Pozo D (2003). Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res. 35: 204-211. (Pubitemid 37100399)
84. Lerner AB, Case JD, Takahashi Y, Lee Y, Mori W (1958). Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc. 80: 2587.
85. Lerner AB, Case JD, Heinzelmann RV (1959). Structure of melatonin. J Am Chem Soc. 81: 6084-6085.
86. Lupowitz Z, Zisapel N (1999). Hormonal interactions in human prostate tumor LNCaP cells. J Steriod Biochem Mol. Biol. 68: 83-88. (Pubitemid 29130389)
87. Manchester LC, Tan DX, Reiter RJ, Park W, Monis K, Qi W (2000). High levels of melatonin in the seeds of edible plants: possible function in germ cell protection. Life Sci. 67: 3023-3029.
88. Malpaux B, Tricoire H, Mailliet F, Daveau A, Migaud M, Skinner DC, et al. (2002). Melatonin and seasonal reproduction: understanding the neuroendocrine mechanisms using the sheep as a model. Reproduction Supplement. 59: 167-179.
89. Marelli MM, Limonta P, Maggi R, Motta M, Moretti RM (2000). Growth inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells. Prostate. 45: 238-244.
90. Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, Manchester LC, Reiter RJ (2010). Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem. 17: 4462-4481.
91. Milczarek R, Hallmann A, Sokolowska E, Kaletha K, Klimek J (2010). Melatonin enhances antioxidant action of α-tocopherol and ascorbate against NADPH- and iron-dependent lipid peroxidation in human placental mitochondria. J Pineal Res. 49: 149-155.
92. Mo JW, Ogorevc B, Zhang X, Pihlar B (2001). Cobalt and copper hexacyanoferrate modified carbon fiber microelectrode as an all-solid Potentiometrie microsensor for hydrazine. Electroanalysis. 12: 48-54.
93. Molina-Carballo A, Munoz-Hoyos A, Reiter RJ, Sanchez-Forte M, Moreno-Madrid F, Rufo-Campos M, et al. (1997). Utility of high doses of melatonin as adjunctive anticonvulsive therapy in a child with severe myoclonic epilepsy: two years' experience. J Pineal Res. 23: 97-105. (Pubitemid 127731744)
94. Murch SJ, Saxena PK (2006). A melatonin-rich germplasm line of St. John's wort (Hypericum perforatum L.). J Pineal Res. 41: 284-287. (Pubitemid 44337726)
95. Murch SJ, Campbell SS, Saxena RK (2001). The role of serotonin and melatonin in plant morphogenesis: regulation of auxin-induced root organogenesis in in vitro-cultured expiants of St. John's wort (Hypericum perforatum L.). In Vitro Cell Dev Biol Plant. 37: 786-793. (Pubitemid 34043086)
96. Murch SJ, Alan AR, Cao J, Saxena PK (2009). Melatonin and serotonin in flowers and fruits of Datura metel L. J Pineal Res. 47: 277-283.
97. Murch SJ, Hall BA, Le CH, Saxena PK (2010). Changes in the levels of indoleamine phytochemicals during veraison and ripening of wine grapes. J Pineal Res. 49: 95-100.
98. Nagai R, Watanabe K, Wakatsaki A, Hamada F, Shinohara K, Hayashi Y, et al. (2008). Melatonin preserves fetal growth in rats by protecting against ischemia/reperfusion-induced oxidative/nitrosative mitochondrial damage in the placenta. J Pineal Res. 45: 271-276.
99. Nakamura Y, Tamura H, Takayama H, Kato H (2003). Increased endogenous level of melatonin in preovulatory human follicles does not directly influence progesterone production. Fertil Steril. 80: 1012-1016. (Pubitemid 37230040)
100. Niles LP, Wang J, Shen L, Lobb DK, Younglai EV (1999). Melatonin receptor mRNA expression in human granulosa cells. Mol Cell Endocrinol. 156: 107-110. (Pubitemid 29460749)
101. Okatani Y, Okamoto K, Hayashi K, Wakatsuki A, Tamura S, Sagara Y (1998). Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res. 25: 129-134. (Pubitemid 28430591)
102. Okazaki M, Higuchi K, Hanawa Y, Shiraiwa Y, Ezura H (2009). Cloning and characterization of Chlamydomonas reinhardtii cDNA arylalkylamine N-acetyltransferase and its use in the genetic engineering of melatonin content in the Micro-Tom tomato. J Pineal Res. 46: 373-382.
103. Okazaki M, Higuchi K, Aouini A, Ezura H (2010). Lowering intercellular melatonin levels by transgenic analysis of indoleamine 2, 3-dioxygenase from rise in tomato plants. J Pineal Res. 49: 239-247.
104. Ortiz A, Espino J, Bejarano I, Lozano GM, Monllor F, Garcia JF, et al. (2011). High endogenous melatonin concentrations enhance sperm quality and short term in vitro exposure to melatonin improves aspects of sperm motility. J Pineal Res. 50: 132-139.
105. Pacini N, Borzani F (2009). Action of melatonin on bone marrow depression induced by cyclophosphamide in acute toxic phase. Neuroendocrinol Lett. 30: 582-591.
106. Padillo FJ, Ruiz-Rabelo JF, Cruz A, Perea MD, Tasset I, Montilla P, et al. (2010). Melatonin and celecoxib improve the outcomes in hamsters with experimental pancreatic cancer. J Pineal Res. 49: 264-270.
107. Pang SF, Pang CS, Poon AM, Lee PP, Liu ZM, Shiu SY (1998). Melatonin: a chemical photoperiodic signal with clinical significance in humans. Clin Med J. 111: 197-203. (Pubitemid 28152602)
108. Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM (2010). Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res. 48: 297-310.
109. Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ (2009). Phytomelatonin: a review. J Exp Bot. 60: 57-69.
110. Park SY, Jang WJ, Yi EY, Jang JY, Jung Y, Jeong JW, et al. (2010). Melatonin suppresses tumor angiogenesis by inhibiting HIF-1a stabilization under hypoxia. J Pineal Res. 48: 178-184.
111. Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Reiter RJ, Swarnakar S (2008). Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res. 44: 439-449. (Pubitemid 351533529)
112. Pevet P, Reinharz AC, Dogterom J (1980). Neurophysins, vasopressin and oxytocin in the bovine pineal gland. Neurosci Lett. 16: 301-306. (Pubitemid 10100896)
113. Philo R, Berkowitz AS (1988). Inhibition of Dunning tumor growth by melatonin. J Urol. 139: 1099-1102.
114. Poeggeler B, Balzer I, Hardeland R, Lerchl A (1991). Pineal hormone melatonin oscillates also in the dinoflagellate Gonyaulax polyedra. Naturwissenschaften. 78: 268-269.
115. Posmyk MM, Janas KM (2009). Melatonin in plants - scientific and practical aspect. In: Progress in Environmental Science and Technology, Vol II, Part A, Editors: Li SC, Wang YJ, Cao FX, Huang P, Zhang Y, Science Press, Beijing 370-376.
116. Posmyk MM, Balabusta M, Janas KM (2009). Melatonin applied by osmopriming as a biostimulator improving cucumber (Cucumis sativus L.) seedling growth at abiotic stress conditions. In: Progress in Environmental Science and Technology, Vol II, Part A, Editors: Li SC, Wang YJ, Cao FX, Huang P, Zhang Y, Science Press, Beijing 362-369.
117. Pozo MJ, Gomez-Pinille PJ, Camello-Almaraz E, Martin-Cano FE, Pascua P, Rol MA, et al. (2010). Melatonin: a potential therapeutic agent for smooth muscle-related pathological conditions and aging. Curr Med Chem. 17: 4150-4165.
118. Prabakar SJR, Narayanan SS (2008). Amperometric determination of hydrazine using surface modified nickel hexacyanoferrate graphite electrode fabricated following a new approach. J Electroanal Chem. 617: 111-120.
119. Proietti S, Cucina A, D'Anselmi F, Dinicola S, Pasqualato A, Lisi E, et al. (2011). Melatonin and vitamin D3 synergistically down-regulate Akt and MDM 2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells. J Pineal Res. 50: 150-158.
120. Quay WB (1956). Volumetric and cytologic variation in the pineal body of Peromyscus leucopus (Rodentia) with respect of sex, captivity and day-length. J Morphol. 471-495.
121. Quay WB (1963). Circadian rhythm in rat pineal serotonin and its modifications by estrous cycle and photoperiod. Gen Comp Endocrinol. 3: 473-479.
122. Reed VA (2011). Shift work, light at night, and the risk of breast cancer. Am. Assoc. Occupt Health Nutri. J. 58: 37-45.
123. Reilly CA, Aust SD (1997). Peroxidase substrates stimulate the oxidation of hydrazine to metabolites which cause single-strand breaks in DNA. Chem Res Toxicol. 10: 328-334. (Pubitemid 27137144)
124. Reiter RJ (1973). Pineal control of a seasonal reproductive rhythm in male golden hamsters exposed to natural daylight and temperature. Endocrinology. 92: 423-430.
125. Reiter RJ (1974). Circannual reproductive rhythms in mammals related to photoperiod and pineal function: a review. Chronobiologia. 1: 365-395.
126. Reiter RJ (1980). The pineal gland; a regulator of regulators. Prog Psychobiol Physiol Psychol. 9: 323-356.
127. Reiter RJ (1991). Melatonin: that ubiquitously acting pineal hormone. News Physiol Sci. 6: 223-227.
128. Reiter RJ, Fraschini F (1969). Endocrine aspects of the mammalian pineal gland: a review. Neuroendocrinology. 5: 219-255.
129. Reiter RJ, Hester RJ (1966). Interrelationships of the pineal gland, the superior cervical ganglia and the photoperiod in the regulation of the endocrine systems of hamsters. Endocrinology. 79: 1168-1170.
130. Reiter RJ, Vaughan MK, Blask DE, Johnson LY (1974). Melatonin: its inhibition of pineal antigonadotropic activity in male hamsters. Science. 185: 1169-1171.
131. Reiter RJ, Blask DE, Johnson LY, Rudeen PK, Vaughan MK, Waring PJ (1976). Melatonin inhibition of reproduction in the male hamster: its dependency on time of day of administration and on an intact and sympathetically innervated pineal gland. Neuroendocrinology. 22: 107-116. (Pubitemid 8115045)
132. Reiter RJ, Richardson BA, Johnson LY, Ferguson BN, Dinh DT (1980). Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science. 210: 1272-1273.
133. Reiter RJ, Craft CM, Johnson JE Jr, King TS, Richardson BA, Vaughan GM, et al. (1981). Age-associated reduction in nocturnal pineal melatonin levels in female rats. Endocrinology. 109: 1295-1297. (Pubitemid 11008322)
134. Reiter RJ, Tan DX, Sainz RM, Mayo JC (2002a). Melatonin protects the heart against both ischemia/reperfusion injury and chemotherapeutic drugs. Cardiovasc Drugs Ther. 16: 5-6. (Pubitemid 34606605)
135. Reiter RJ, Tan DX, Sainz RM, Mayo JC, Lopez-Burillo S (2002b). Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol. 54: 1299-1321. (Pubitemid 35174175)
136. Reiter RJ, Tan DX, Allegra M (2002c). Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants. Neuroendocrinol Lett. 23 (Supplement 1): 1-8.
137. Reiter RJ, Manchester LC, Tan DX (2005). Melatonin in walnuts: influence on melatonin levels and total antioxidant capacity of blood. Nutrition. 21: 920-924. (Pubitemid 41188090)
138. Reiter RJ, Tan DX, Manchester LC, Simopoulus AP, Maldonado MD, Flores LJ, et al. (2007a). Melatonin in edible plants (phytomelatonin): identification, concentrations, bioavailability and proposed functions. World Rev Nutr Diet. 97: 211-230.
139. Reiter RJ, Tan DX, Manchester LC, Terron MP, Flores LJ, Koppisetti S (2007b). Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci. 52: 11-28.
140. Reiter RJ, Korkmaz A, Paredes SD, Manchester LC, Tan DX (2008a). Melatonin reduces oxidative/nitrosative stress due to drugs, toxins, metals, and herbicides. Neuroendocrinol Lett. 29: 609-613.
141. Reiter RJ, Tan DX, Jou MJ, Korkmaz A, Manchester LC, Paredes SD (2008b). Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites. Neuroendocrinol Lett. 29: 391-398.
142. Reiter RJ, Paredes SD, Manchester LC, Tan DX (2009a). Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol. 44: 175-200.
143. Reiter RJ, Tan DX, Erren TC, Fuentes-Broto L, Paredes SD (2009b). Light-mediated perturbation of circadian timing and cancer risk: a mechanistic analysis. Integr Cancer Ther. 8: 354-360.
144. Reiter RJ, Tan DX, Manchester LC, Paredes SD, Mayo JC, Sainz RM (2009c). Melatonin and reproduction revisited. Biol Reprod. 81: 445-456.
145. Reiter RJ, Tan DX, Fuentes-Broto L (2010a). Melatonin: a multitasking molecule. Prog Brain Res. 181: 127-151.
146. Reiter RJ, Tan DX, Paredes SD, Fuentes-Broto L (2010b). Beneficial effects of melatonin in cardiovascular disease. Ann Med. 42: 276-285.
147. Revel FG, Masson-Pevet M, Pevet P, Mikkelsen JD, Simonneaux V (2009). Melatonin controls seasonal breeding by a network of hypothalamic targets. Neuroendocrinology. 90: 1-14.
148. Richter HG, Hansell JA, Raut S, Giussani DA (2009). Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J Pineal Res. 46: 357-364.
149. Rodella LF, Filippini F, Bonomini F, Bresciani R, Reiter RJ, Rezzani R (2010). Beneficial effects of melatonin on nicotine-induced vasculopathy. J Pineal Res. 48: 126-132.
150. Rodin AE (1963). The growth and spread of Walker 256 carcinoma in pinealectomized rats. Cancer Res. 27: 1545-1548.
151. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, et al. (2004). Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 36: 1-9. (Pubitemid 38130283)
152. Rodriguez ML, Carretero M, Escames G, Lopez LC, Maldonado MD, Tan DX, et al. (2007). Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence-accelerated mice. Free Radic Res. 41: 15-24. (Pubitemid 44896871)
153. Romero A, Egea J, Garcia AG, Lopez MG (2010). Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells. J Pineal Res. 49: 141-148.
154. Rosenstein RE, Pandi-Perumal SR, Srinivasan V, Spence DW, Brown GM, Cardinali DP (2010). Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis. J Pineal Res. 49: 1-13.
155. Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM (1986). Human melatonin production decreases with age. J Pineal Res. 3: 379-388. (Pubitemid 17184633)
156. Saftlas AF, Olson DR, Franks AC, Atrash HK, Potaras R (1990). Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 163: 455-460.
157. Sainz RM, Mayo JC, Rodriguez C, Tan DX, Lopez-Burillo S, Reiter RJ (2003). Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci. 60: 1407-1426. (Pubitemid 36900523)
158. Sainz RM, Mayo JC, Tan DX, Leon J, Manchester LC, Reiter RJ (2005). Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate. 63: 29-43. (Pubitemid 40365388)
159. Salafia CM, Vintzileos AM, Silberman L, Bantham KF, Vogel CA (1992). Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol. 9: 179-184.
160. Scheer FA (2005). Potential use of melatonin as an adjunct antihypertensive therapy. Am J Hypertens. 18 (12 Pt 1): 1619-1620.
161. Scherbarth F, Steinlechner S (2010). Endocrine mechanisms of seasonal adaptation in small mammals: from early results to present understanding. J Comp Physiol. 180: 935-952.
162. Schernhammer E, Kroenke CH, Laden F, Hankinson SE (2006). Night work and risk of breast cancer. Epidemiology. 17: 108-111.
163. Schmidt W (2001). Hydrazine and Its Derivatives: Preparation, Properties, Applications. Vol 1, Wiley-Interscience, New York Chapter 4.
164. Sharkey JT, Cable C, Olcese J (2010). Melatonin sensitizes human myometrial cells to oxytocin in a protein kinase C alpha/extracellular-signal regulated kinase-dependent manner. J Clin Endocrinol Metab. 95: 2902-2908.
165. Sharman EH, Sharman KG, Bondy SC (2011). Extended exposure to dietary melatonin reduces tumor number and size in aged male mice. Exp Gerontol. 48: 18-22.
166. Shiu SY (2007). Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment. J Pineal Res. 43: 1-9.
167. Shiu SY, Law KW, Tam PC, Yip AW, Ng WT (2003). Melatonin slowed the early biochemical progression of hormone refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype. J Pineal Res. 35: 177-182. (Pubitemid 37100395)
168. q proteins. J Pineal Res. 49: 301-311.
169. Siddiqui IA, Jaleel A, Tamimi W, Al Kadri HM (2010). Role of oxidative stress in the pathogenesis of pre-eclampsia. Arch Gynecol Obstet. 282: 469-474.
170. Simko F, Pechanova O (2009). Potential role of melatonin and chronotherapy among new trends in hypertension treatment. J Pineal Res. 47: 127-133.
171. Skinner DC, Malpaux B (1999). High melatonin concentrations in the third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating though the choroid plexus. Endocrinology. 140: 4399-4405. (Pubitemid 30666101)
172. Soares JM Jr, Masana Ml, Ersahin C, Dubocovich ML (2003). Functional melatonin receptors in rat ovaries at various stages of the estrous cycle. J Pharmacol Exp Ther. 306: 694-702.
173. Srinivasan V, Spence DW, Moscovitch A, Pandi-Perumal SR, Trakht I, Brown GM, et al. (2010). Malaria: therapeutic implications of melatonin. J Pineal Res. 48: 1-8.
174. Stankov B, Reiter RJ (1990). Melatonin receptors: current status, facts and hypothesis. Life Sci. 46: 971-982. (Pubitemid 20150552)
175. Stankovich S, Dikin DA, Piner RD, Kohlhaas KA, Klienhammer A, Jia Y, et al. (2007). Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide. Carbon. 45: 1558-1565. (Pubitemid 46829016)
176. Stasiak M, Zasada K, Lewinski A, Karbownik-Lewinska M (2010). Melatonin restores the basal level of lipid peroxidation in rat tissues exposed to potassium bromate in vitro. Neuroendocrinol Lett. 31: 363-369.
177. Stevens RG, Davis S (1996). The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect. 104 (Suppl 1): 135-140. (Pubitemid 26123098)
178. Succu S, Berlinguer F, Pasciu V, Satta V, Leoni G, Naitana S (2011). Melatonin protects ram spermatozoa from cryopreservation injuries in a dose-dependent manner. J Pineal Res. 50: 310-318.
179. Sugino N (2005). Reactive oxygen species in ovarian physiology. Reprod Med Biol. 4: 31-44.
180. Sugino N (2007). Roles of reactive oxygen species in the corpus luteum. Anim Sci J. 77: 556-565.
181. Swarnakar S, Paul S, Signh LP, Reiter RJ (2011). Matrix metalloproteinases in health and disease: regulation by melatonin. J Pineal Res. 50: 8-20.
182. Tamarkin L, Westrom WK, Hamill AI, Goldman BD (1976). Effect of melatonin on the reproductive systems of male and female Syrian hamsters: diurnal sensitivity to melatonin. Endocrinology. 99: 1534-1541. (Pubitemid 8003988)
183. Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N, et al. (2009). Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril. 92: 328-343.
184. Tamura H, Nakamura Y, Terron MP, Flores LJ, Manchester LC, Tan DX, et al. (2008a). Melatonin and pregnancy in the human. Reprod Toxicol. 25: 291-303.
185. Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, et al. (2008b). Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rates. J Pineal Res. 44: 280-287. (Pubitemid 351392942)
186. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ (1993). Melatonin: a potent, endogenous hydroxyl radial scavenger. Endocr J. 1: 57-60.
187. Tan DX, Manchester LC, Reiter RJ, Qi W, Hanes MA, Farley NJ (1999). High physiological levels of melatonin in the bile of mammals. Life Sci. 65: 2523-2529.
188. Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, et al. (2002). Chemical and physical properties and potential mechanisms: metabolisms as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem. 2: 181-187.
189. Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S, Mayo JC, Sainz RM, et al. (2003). Melatonin: a hormone, a tissue factor, an autocoid, a paracoid and an antioxidant vitamin. J Pineal Res. 34: 75-78.
190. Tan DX, Manchester LC, Di Mascio P, Martinez GR, Prado FM, Reiter RJ (2007a). Novel rhythms of N1-acetyl-N2-formyl-5-methoxykynuramine and its precursor melatonin in water hyacinth: importance in phytoremediation. FASEB J. 21: 1724-1729. (Pubitemid 46855618)
191. Tan DX, Manchester LC, Helton P, Reiter RJ (2007b). Phytoremediative capacity of plants enriched with melatonin. Plant Signal Behav. 2: 514-516.
192. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ (2008). One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen derivatives? J Pineal Res. 42: 1-11.
193. Tan DX, Manchester LC, Sanchez-Barcelo E, Mediavilla MD, Reiter RJ (2010). Significance of high levels of endogenous melatonin in mammalian cerebrospinal fluid and in the central nervous system. Curr Neuropharmacol. 8: 162-167.
194. Tanaka M, Natori M, Ishimoto T, Miyozaki T, Kobayashi T, Nozawa S (1994). Experimental growth retardation produced by transient period of utero-placental ischemia in pregnant SpragueDawley rats. Am J Obst Gynec. 171: 123-124.
195. Torres-Farfan C, Rocco V, Monso C, Valenzuela FJ, Campino C, Germain A, et al. (2006). Maternal melatonin effects on clock gene expression in a nonhuman primate fetus. Endocrinology. 147: 4618-4626. (Pubitemid 44402167)
196. Vaughan GM, Pelham RW, Pang SF, Laughlin LL, Wilson KW, Sandock KL, et al. (1976). Nocturnal elevation of plasma melatonin and urinary 5-hydroxyindoleacetic acid in young men: attempts at modification by brief changes in environmental lightening and sleep and by autonomic drugs. J Clin Endocrinol Metab. 42: 752-764.
197. Vidal A, Medigue C, Malpaux B, Clement F (2009). Endogenous circannual rhythm in luteinizing hormone secretion: insight from signal analysis coupled with mathematical modeling. Philos Transact A Math Phys Eng Sci. 367: 4759-4777.
198. Wakatsuki A, Okatani Y, Izumiya C, Ikenoue N (1999). Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain. J Pineal Res. 26: 147-152. (Pubitemid 29183117)
199. Wiktorska JA, Lewinski A, Stuss M, Nowak D, Pietras T, Sewerynek E (2010). Effects of certain antioxidants on lipid peroxidation process in lung homogenates of L-thyroxine-receiving rats. Neuroendocrinol Lett. 31: 137-146.
200. Woo MM, Tai CJ, Kang SK, Nathwani PS, Pang SF, Leung PCK (2001). Direct action of melatonin in human granulosa-luteal cells. J Clin Endocrinol Metab. 86: 4789-4797. (Pubitemid 33020521)
201. Yie SM, Brown GM, Liu GY, Collins JA, Daya S, Hughes EG (1995). Melatonin and steroids in human pre-ovulatory follicular fluid: seasonal variations and granulosa cell steroid production. Hum Reprod. 10: 50-55.
202. Yoo YM, Jeung EB (2010). Melatonin suppresses cyclosporine Á-induced autophagy in rat pituitary GH3 cells. J Pineal Res. 48: 204-211.
203. Yuan L, Collins AR, Dai J, Dubocovich ML, Hill SM (2002). MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. MoI Cell Endocrinol. 192: 147-156. (Pubitemid 34667233)
204. Zeller JM, Henig I, Radwanska E, Dmowski WP (1987). Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am J Reprod Immunol Microbiol. 13: 78-82. (Pubitemid 17075991)
205. Zhao Y, Qi LW, Wang WM, Uchendu E, Saxena PK, Liu CZ (2011). Melatonin improves the survival of cryopreserved callus of Rhodiola crenulata. J Pineal Res. 50: 83-88.